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1030Background: Aortic valve replacement leads to improvement of coronary flow but not to complete normaliza-
tion. Coronary hypoperfusion contributes to higher left ventricular mass persistence, arrhythmias, congestive
heart failure and sudden death. This prospective study compares 2 similarly sized aortic prostheses (mechanical
and porcine) regarding coronary flow and hemodynamic performances in patients who underwent surgery for
pure aortic stenosis.
Methods: Sixty patients having undergone aortic valve replacement for pure aortic stenosis withMedtronicMo-
saic Ultra bioprosthesis 21 mm (n ¼ 30) or St Jude Regent mechanical valve 19 mm (n ¼ 30) were evaluated
preoperatively and 12 months postoperatively comparing the coronary flow and the hemodynamic behavior.
Echocardiography and cardiac positron emission tomography were performed at rest and during exercise or
adenosine maximal stimulation, respectively.
Results: The St Jude Regent mechanical valve, compared with the Medtronic Mosaic Ultra bioprosthesis, had
reduced coronary flow reserve (2.1 0.3 vs 2.3 0.2;P¼ .003), less favorable systolic/diastolic time ratio (0.87
 0.02 vs 0.78 0.03; P<.001), and higher mean transprosthetic gradient (46 11 vs 38 9; P¼ .003) during
exercise. Multivariate analysis of impaired coronary reserve related indexed effective orifice area less than 0.65
cm/m2 (risk ratio [RR], 1.9; 95% confidence intervals [CI], 1.5-2.8; P<.001), mechanical valve (RR, 2.5; 95%
CI, 1.7-3.3; P<.001), and systolic/diastolic time ratio greater than 0.75 (RR, 2.6; 95% CI, 1.8-3.8; P<.001), as
well as high transprosthetic gradient (RR, 1.7; 95%CI, 1.3-2.4;P<.001) ) during exercise with coronary reserve
less than 2.2.
Conclusions: Improvement of coronary flow and reserve was more evident for bioprostheses than for mechan-
ical valves. The bioprostheses demonstrated superior hemodynamics during exercise, which may have some im-
pact on exercise capability during normal daily life. (J Thorac Cardiovasc Surg 2012;143:1030-5)Myocardial blood flow (MBF) and coronary flow reserve
(CFR) are reduced in patients with severe aortic stenosis.
Aortic valve replacement (AVR) leads to improvement of
coronary flow but not to complete normalization.1-4
Chronic coronary hypoperfusion might contribute to
cardiac events such as congestive heart failure and
sudden cardiac death and might be related to persistence
of high left ventricular mass.1,5-8 Recent experimental
studies hypothesized that, besides other variables,
impaired coronary flow after AVR should be ascribed to
a disturbed flow pattern in the proximal part of the aorta
distal to the valve and suggested that valve size and
design as well as residual transprosthetic gradient may
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The Journal of Thoracic and Cardiovascular Surcoronary perfusion also influenced by diastolic time,
which is usually impaired after AVR, few data are
available on the relationships between diastolic duration
and coronary perfusion regarding the different behavior
of mechanical and biological valve substitutes.
This study was designed to evaluate the impact of aortic
valve design on MBF by means of several pathophysiologic
and hemodynamic parameters measured at rest and during
exercise. Two homogeneous groups of patients who re-
ceived a similarly sized aortic prosthesis, divided according
to mechanical or biological prostheses implanted, were
compared. Cardiac cycle abnormalities and hemodynamic
parameters were measured by Doppler echocardiography
at rest and during exercise. MBF and CFR were evaluated
by cardiac positron emission tomography (PET) at rest
and during pharmacologically induced hyperemia.MATERIAL AND METHODS
Description of the Implanted Prostheses
To obtain 2 homogeneous groups and avoid any misleading interfer-
ence owing to comparison of prostheses different in size, design, and struc-
ture, we aimed to perform an ‘‘actual size’’ analysis between 2 valve
substitutes and held more realistic to evaluate patients with an aortic annu-
lus of 20 mm (the most common size of aortic annulus in prostheticgery c May 2012
Abbreviations and Acronyms
AVR ¼ aortic valve replacement
CFR ¼ coronary flow reserve
CI ¼ confidence intervals
LVDT ¼ left ventricular diastolic time
LVET ¼ left ventricular ejection time
MBF ¼ myocardial blood flow
MMU ¼ Medtronic Mosaic Ultra
PET ¼ positron emission tomography
RR ¼ risk ratio
SJR ¼ St Jude Medical Regent
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Dimplants for pure aortic stenosis). For the purpose of this study, we selected
the St Jude Medical Regent (SJR) (St Jude Medical Inc, St Paul, Minn)
19-mm valve as the mechanical valve and the Medtronic Mosaic Ultra
(MMU) (Medtronic Inc, Minneapolis, Minn) 21-mm valve as the
bioprosthesis.
Differently sizedmechanical (SJR 19mm) and biologic (MMU 21mm)
prostheses were chosen because of the sizer provided by the manufac-
turers; the 21-mm MMU is clearly smaller (19.5 mm) than the 21-mm
SJR (21 mm) when measured with slide callipers.11 Conversely, the actual
external sewing ring diameter, which is the maximum diameter of a pros-
thesis, was similar in SJR 19-mm andMMU 21-mm valves (19 mm vs 19.5
mm, respectively), as well as the internal orifice diameter, which is the
factor that mainly affects the effective orifice area (17.8 mm vs 17.5,
respectively).
Patient Population
Between January 2007 and August 2009, a total of 189 patients under-
going AVR for pure aortic stenosis with an aortic annulus of 19 to 21 mm,
determined after adequate (transthoracic and/or transesophageal) echocar-
diographic examination, were evaluated for inclusion in the study. All pa-
tients had aortic maximum gradient greater than 50 mm Hg and/or aortic
valve area less than 1.0 cm2 and angiographically normal coronary arteries
before surgery. Mean age was 62.2 7.2 years (range, 55-69 years). To ob-
tain a study population as homogeneous as possible and to avoid any con-
founding interference on results, we used the following exclusion criteria:
age less than 55 years or over 70 years, active endocarditis, emergency sur-
gery, previous cardiac surgery, bicuspid aortic valve, associated aortic dis-
eases, simultaneous mitral or tricuspid replacement or repair, poor cardiac
function as indicated by ejection fraction less than 40%, chronic atrial fi-
brillation, severe comorbidities (dialysis, hepatic failure, autoimmune dis-
ease), impediments to exercise test (neurologic or osteoarticular), and
contraindications to receive adenosine (heart block or reactive respiratory
disease). Thirty patients received a 21-mm MMU bioprosthesis (MMU
group) and 30 a 19-mm SJR mechanical bileaflet valve (SJR group). The
choice was based on history of thomboembolism or bleeding disorders,
liver disease, and preference of the patient or cardiologist.
All patients from both groups underwent echocardiographic (transtho-
racic or transesophageal) evaluations and PET scans at rest within a
2-week preoperative period. Postoperative echocardiographic assessment
at rest and during exercise as well as PET scans at rest and during maximal
adenosine stimulation were performed 12 months after surgery. Follow-up
was started at 12 months because prosthetic gradients usually change dur-
ing the first postoperative year with significant impact either on the exercise
capability or on the hemodynamic results.11
The Institutional Research Ethics Committee of the University of Na-
ples approved this study and all patients provided written informed
consent.The Journal of Thoracic and CarSurgical Technique
The surgical approach consisted in median sternotomy, hollow-fiber ox-
ygenators, and a centrifugal blood pump. The ascending aorta and right
atrium were cannulated. Pump flow was kept at about 2.5 L $ min1 $
m2 and the arterial pressure at about 70 mmHg. The myocardiumwas pro-
tected by intermittent cold crystalloid cardioplegia. Aortic annulus diame-
ter was measured by Hegar dilators. Thereafter, prosthetic valve size was
determined by using the original sizer by eachmanufacturer. All prostheses
were implanted with 2-0 polyester nonpledget-supported, interrupted, non-
everting mattress sutures. Mean aortic crossclamping timewas 65.4 20.3
minutes. The MMU valves were implanted according to the manufacturer
recommendations regarding the asymmetric design. The SJR valves were
implanted respecting the optimum hemodynamic orientation achieved
with one orifice facing the right coronary cusps.8 Patients with the SJM
valve received postoperative lifelong warfarin anticoagulation. Patients
with the MMU bioprosthesis received warfarin for 8 to 12 weeks only.
Echocardiographic Measurements and Calculations
The echocardiographic examinations were performed according to the
recommendations of the American Society of Echography.12 Left ventric-
ular function was evaluated by the ejection fraction calculated by the Simp-
son rule. The left ventricular mass was normalized to body surface area.
Left ventricular hypertrophy was defined as indexed left ventricular mass
more than 130 g/m2 in men and more than 100 g/m2 in women.13 The
peak and mean prosthetic gradients were calculated from continuous-
wave Doppler measurements using the modified Bernoulli equation. Stroke
volume was indexed for body surface area. The continuity equation was
used to calculate the effective orifice area.
Valve regurgitation was assessed by color flow Doppler mapping and
continuous-wave Doppler (transthoracic or transesophageal) as the total
backflow volume occurring after the aortic prostheses was fully closed.
The evaluation of the SJR was possible only by the optimal orientation
of the viewing plane as a consequence of the more complex arrangement
of regurgitant jets.
Left ventricular ejection time (LVET) was measured on the continuous-
wave Doppler trace from opening to closing of the aortic valve. Left ven-
tricular diastolic time (LVDT) was determined as R-R interval–LVET.
LVET/LVDT ratio was assessed as well. All measurements are given as
the average of 3 consecutive cardiac cycles at rest or 10 cycles during
exercise.
Exercise Protocol
Stress test was performed in all patients 5 days after therapy withdrawal.
The exercise test was performed with the patients exercising in the supine
position and was conducted according to a standard protocol starting from
a workload of 25 W and increased by 25 W at 2-minute intervals. The ref-
erence workload for healthy individuals was 2.5 W/kg in women and 3.0
W/kg in men between 21 and 30 years, minus 10% for each decade. Tests
were limited by symptoms, blood pressure greater than 180/100 mm Hg,
arrhythmias, and exhaustion or achievement of 100% of age and/or sex ref-
erenceworkload. The evaluation of LVETandLVDTwas obtained at a heart
rate of 100 beats/min while peak prosthetic gradient, mean prosthetic gra-
dient, and effective orifice area were assessed at peak exercise.
Quantification of MBF
Cardiac PET was performed on a Siemens ECAT EXACT
3-dimensional positron scanner (Siemens AG, Munich, Germany). PET
perfusion tracer was 13NH3 given intravenously as a bolus. Rest and stress
arterial radiopharmaceutical administration consisted of 370 to 740 MBq
(10-20 mCi) of 13NH3. All substances that interfere with adenosine meth-
abolism, such as caffeine and other methylxanthine derivatives, were with-
held 12 hours before the study. Regions of interest were septal, anterior,
lateral, and posterior walls of the left ventricle in the apical, mid, and basaldiovascular Surgery c Volume 143, Number 5 1031
TABLE 1. Preoperative and surgical variables
Mosaic Ultra
(n ¼ 30)
St Jude Medical
Regent (n ¼ 30)
P
value
Male sex 19 (63.3%) 21 (70%) .7
Age (y) 64  5 63  3 .3
BSA m2 1.91  0.21 2.01  0.27 .1
BMI 27.5  2.2 27.8  2.6 .6
Moderate PPM 21 (70%) 22 (73.3%) 1
Severe PPM 9 (30%) 8 (26.7%) 1
EOAi (cm2/m2) 0.73  0.07 0.75  0.08 .3
LVEF (%) 58  9 56  7 .7
ILVM ( g/m2) 171  51 165  49 .6
CI (L/min/m2) 2.28  0.3 2.32  0.5 .7
ISV (mL/beat/m2) 28  6 30  7 .2
Crossclamp time (min) 58  16 62  15 .3
Pump time (min) 78  17 79  21 .8
ICU stay (hours) 32  11 33  9 .7
Hospital stay (days) 7.3  3.2 7.8  6.1 .6
Values are expressed as mean standard deviation or number (%). The P value was
determined by analysis of variance or c2 test (gender, moderate PPM, severe PPM).
BSA,Body surface area; BMI, bodymass index; PPM, prosthesis-patient mismatch;
EOAi, indexed effective orifice area; LVEF, left ventricular ejection fraction; ILVM,
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Dplanes. Tissue time activity curves were generated from the dynamic image
and fitted to a single tissue compartment tracer kinetic model to give values
of MBF (mL $ min1 $ g1). Coronary flow was measured at baseline and
after maximal hyperemic response obtained within 90 seconds of venous
adenosine infusion (140 mg $ kg1 $min1). The CFR was the ratio between
hyperemic and baseline MBF.
Statistical Analysis
Data were analyzed by SPSS version 15 for Windows (SPSS, Inc,
Chicago, Ill). Comparison between continuous variables was done
by the Student t test for normally distributed features. The Mann-
Whitney U test was used for variables not normally distributed. Cate-
gorical variables were analyzed by c2 test or Fisher’s exact test as
appropriate. Continuous data are presented as mean  standard devia-
tion and categorical data as proportion. Factors influencing coronary
flow were analyzed by calculating the risk ratio (RR) with 95% confi-
dence intervals (CI). Multivariate logistic analysis was performed with
a stepwise regression model, in which each variable with a P value
 .05 (on the basis of univariate analysis) was entered into the model.
The variables tested in the models were as follows: sex, body surface
area, preoperative indexed left ventricular mass, indexed effective ori-
fice area, type of prosthesis implanted, CFR during hyperemic stimula-
tion, mean prosthetic gradient greater than 50 mm Hg, LVDT, and
LVET/LVDT ratio during exercise.
indexed left ventricular mass; CI, cardiac index; ISV, indexed stroke volume; ICU,
intensive care unit; moderate PPM, EOAi < 0.85 and > 0.65; severe PPM,
EOAi<0.65.RESULTS
Patient Characteristics
Demographics were similar for MMU and SJR valve
recipients. The incidence of severe prosthesis-patient
mismatch was similar in both groups. Mean indexed ori-
fice area was 0.73  0.07 in patients from the MMU group
versus 0.75  0.08 in patients from the SJR group
(P ¼ .3). Myocardial ischemia and cardiopulmonary by-
pass times were similar for all patients. No differences
were found either in intensive therapy unit stay or hospital
stay (Table 1).
Fifty-two percent of patients received b-blockers, 12%
angiotensin-converting enzyme inhibitors, and 36% had
b-blockers and angiotensin-converting enzyme inhibitor
therapy.Postoperative Echocardiographic Evaluation at Rest
One year after surgery, baseline heart rate, systolic blood
pressure, cardiac index, and indexed stroke volume were
similar in both groups. Peak and mean transvalvular pres-
sure gradients at rest were low in both SJR and MMU
groups (peak 25  9 mm Hg vs 27  11 mm Hg; P ¼ .4;
mean 11  7 mm Hg vs 13  9 mm; P ¼ .3; respectively).
Overall, no significant regression of indexed left ventricular
mass was observed in both groups at either 6 months
(P ¼ .8) or 1 year after surgery (P ¼ .7), although the re-
sponse was heterogeneous at the individual level.
The LVET and LVDT at rest occupied 38%  3% and
62%  5%, respectively, of the cardiac cycle without
any significant difference between groups. Doppler-
derived hemodynamic and myocardial blood flow data at
rest are reported in Table 2.1032 The Journal of Thoracic and Cardiovascular SurThe SJR valve showed a complex arrangement of regur-
gitant jets that were dependent on the orientation of the
viewing plane. In the plane perpendicular to closure line,
2 divergent jets arising in the valve periphery (inverted V
shape) and an additional small regurgitation jet from the
center of the valve were seen. The backflow was significant
(10%-15% of forward flow) in the SJR valve whereas it
was negligible with an MMU valve.
Mechanical valves also showed a high level of systolic
turbulence in the aortic root, although optimally oriented.
Hemodynamic Performance During Exercise
In the MMU group the peak transvalvular gradients in-
creased to 49  1 mm Hg whereas the mean transvalvular
gradients increased to 38  9 mm Hg from baseline. In
the SJR group they increased to 53  12 and to 45  11
mm Hg, respectively, with statistically significant differ-
ences between groups (P<.01) (Figure 1). Effective orifice
area did not changewith flow in patients from the SJR group
at peak exercise, but it was slightly increased in patients
from the MMU group. These results may not be surprising
because bioprostheses are flexible and open more gradually
in response to an increase in flow.
Cardiac cycle duration, which is algebraically depen-
dent on heart rate, fell from a mean of 750 ms at rest to
600 ms during exercise at a heart rate of 100 beats/min.
The LVET decreased during stress from 300  24 ms to
260  12 ms in the MMU group and from 290  21 ms
to 280  15 ms in the SJR group. The LVDT decreased
from 450  25 ms to 340  16 ms in the MMU groupgery c May 2012
TABLE 2. Postoperative Doppler-derived hemodynamic and myocardial blood flow data at rest, during exercise, and after maximal adenosine
stimulation
Baseline Maximal stimulation
MMU 21 mm (n ¼ 30) SJR 19 mm (n ¼ 30) P value MMU 21 mm (n ¼ 30) SJR 19 mm (n ¼ 30) P value
HR (beats/min) 81  13 78  16 .4 100 100
AP (mm Hg) 135  21 130  19 .3 172  31 164  28 .2
CI (L/min) 2.36  0.4 2.30  0.5 .6 4.58  0.43 4.60  0.38 .8
ISV (mL/beat) 30  4 29  5 .4 46  6 46  3 1
MPG (mm Hg) 13  9 11  7 .3 38  9 45  11 .008
PPG (mm Hg) 27  11 25  9 .4 47  10 53  12 .01
AVF (mL/s) 200  35 202  42 .8 338  35 326  41 .2
LVET (ms) 300  24 290  21 .09 260  12 280  15 <.001
LVDT (ms) 450  25 460  19 .07 340  16 320  11 <.001
LVET/LVDT 0.66  0.04 0.64  0.06 .1 0.76  0.03 0.85  0.02 <.001
MBF (mL/min/g) 1.02  0.2 0.96  0.28 .3 2.34  0.32 2.01  0.41 .001
CFR 2.3  0.2 2.1  0.3 .003
Values are expressed as mean standard deviation and p value determined by analysis of variance.MMU,Medtronic Mosaic Ultra; SJR, St Jude Medical Regent;HR, heart rate;
AP, arterial pressure; CI, cardiac index; ISV, indexed stroke volume; MPG, mean prosthetic gradient; PPG, peak prosthetic gradient; AVF, aortic volume flow; LVET, left ven-
tricular ejection time; LVDT, left ventricular diastolic time; MBF, myocardial blood flow; CFR, coronary flow reserve.
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When LVET and LEDT are considered as proportions of
the cardiac cycle, systolic time during exercise increased
from 39%  3% at rest to 44%  4% in the MMU group
and from 38%  4% to 47%  5% in the SJR group
whereas diastolic time decreased from 60%  5% to
56%  5% and from 61%  4% to 53%  4%, respec-
tively. During exercise, at heart rates of 100 beats/min,
LVET/LVDT ratio was lower in the MMU group than in
the SJR group (0.76  0.03 vs 0.85  0.02; P< .001).
Therefore, as a general rule, despite shortening of cardiac
cycle duration during exercise, systole duration was not
linearly related to heart rate. However, the relation be-
tween the duration of systole and diastole and the sys-
tolic/diastolic time ratio were different in the 2 groups
of patients (Table 2).FIGURE 1. Mean prosthetic gradients (MPG) of Medtronic Mosaic Ultra
bioprostheses and St Jude Medical mechanical valve at rest and during
exercise.
The Journal of Thoracic and CarMBF
Resting MBF increased from preoperative 0.87 0.39 to
0.96 0.28 mL $min1 $ g1 (þ9%) at follow-up in the SJR
group and from 0.85 0.38 to 1.02 0.27 mL $min1 $ g1
(þ16%) in theMMUgroup.HyperemicMBF increased from
preoperative 1.46  0.52 to 2.01  0.85 mL $ min1 $ g1
(þ26 %) at follow-up in the SJR group and from
1.47  0.61 to 2.34  0.73 mL $ min1 $ g1 (þ36%) in the
MMU group (Figure 2). CFR increased from preoperative
1.68 to 2.1 (þ20%) at follow-up in the SJR group and from
1.72 to 2.3 (þ26%) in the MMU group (Table 2).Relationships Between Measured Parameters
Multivariate predictors of coronary reserve less than 2.2
during adenosine hyperemic stimulation were indexed ef-
fective orifice area less than 0.65 cm/m2 (RR, 1.9; 95%
CI, 1.5-2.8; P< .001), mechanical valve (RR, 2.5; 95%FIGURE 2. Myocardial blood flow (MBF) of Medtronic Mosaic Ultra
bioprosthesis and St Jude Medical mechanical valve at rest and during
adenosine.
diovascular Surgery c Volume 143, Number 5 1033
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DCI, 1.7-3.3; P<.001), LVET/LVDT ratio greater than 0.75
(RR, 2.6; 95% CI, 1.8-3.8; P<.001), and mean prosthetic
gradient less than 50 mm Hg (RR, 1.7; 95% CI, 1.3-2.4;
P<.001) during exercise.
DISCUSSION
The mechanisms responsible for the only partially recov-
ered coronary flow after AVR have been largely debated.
Rajappan and associates1 demonstrated that the improve-
ment of coronary perfusion is mainly dependent on the im-
provement of valve effective orifice area achieved with
AVR. Nonetheless, although mechanical and biological
valves are usually stenotic to some extent, it was surprising
that only a negligible residual transprosthetic gradient can
impair coronary perfusion.
Besides the variables related tomicrovascular remodeling
and altered distribution of coronary vascular resistance in
patients with high left ventricular mass, Kleine,9 Bakhti-
ary,14,15 and their associates hypothesized that blunted
coronary perfusion should also be ascribed to a disturbed
flow pattern in the proximal part of the aorta distal to the
valve, and they drew the attention to diastolic performance
of valve substitutes. In this regard, they suggested that
different types and orientations of aortic valve prostheses
could affect myocardial perfusion in a different way.9,10
However, the complex pathophysiologic relationship
between coronary flow and different hemodynamic of
mechanical and biological prostheses had not been clearly
elucidated before.
Our results confirmed that AVR led to improvement of
MBF but not to a complete restoration in nearly all patients.
Overall, impaired MBF and reserve during hyperemic stim-
ulation were strongly linked with high indexed left ventric-
ular mass, increased mean prosthetic gradient, and impaired
LVET/LVDT ratio during exercise. However, patients with
mechanical valves had more blunted hyperemic MBF and
CFR and developed significantly higher mean prosthetic
gradients during exercise as compared with patients with bi-
oprostheses. These results confirm that transprosthetic gra-
dient, exacerbated during exercise, could have a detrimental
effect onMBF determined also by the rounded backflow en-
hancing aortic valve closure and by the flow pattern through
the aortic valve and the sinuses of Valsalva. In this regard,
although optimally orientated, the SJR valve developed
a high level of turbulence and had a relatively large total re-
gurgitant volume across the closed valve.16 High systolic
downstream turbulence, closing reflux, and leakage flow
combined to create disturbed flow in the sinuses of Valsalva
and allowed a less physiologic diastolic coronary perfusion.
Conversely, the MMU bioprosthesis demonstrated a central
flow very close to the natural geometry, hallowing a less tur-
bulent flow passage during the systolic phase of cardiac cy-
cle and a physiologic leaflet closure during the diastolic
phase with negligible regurgitation.171034 The Journal of Thoracic and Cardiovascular SurThis study also revealed evident stress-induced abnor-
malities of the cardiac cycle in all patients after AVR. As
is widely known, the total cardiac cycle duration is algebra-
ically dependent on the heart rate (60,000 ms/heart rate),
which is the major determinant affecting diastolic and sys-
tolic duration. Systolic time has a negative linear correlation
with heart rate. Diastolic time has a more complex relation:
it is longer at low heart rates and decreases more markedly
than systolic time during exercise. Coronary perfusion is
a function of both diastolic duration and systolic/diastolic
ratio. The physiologic relationship between diastolic time-
shortening during exercise and coronary perfusion has
been well documented over time.18 However, there are no
prior studies relating to the influence on coronary perfusion
of differing hemodynamic behaviors of mechanical and bi-
ological prostheses after AVR. Our results, despite similar
values at rest in both groups, focused a significantly short-
ened LVDT and LVET/LVDT ratio during exercise in pa-
tients from the SJR group, which were strongly related to
impaired hyperemic MBF.
Hence, the worse performance of the SJR valve during
exercise depends on a number of cofactors, but, in addition,
it could also be attributed to the rigid structure of mechan-
ical valves that destroys completely the delicate physiolog-
ical mechanism of active annulus motion and aortic root
expansion at each phase of the cardiac cycle.19 Conversely,
our study seems to substantiate the key role of highly flex-
ible stent of the MMU valvewhich, during physical activity,
allows better deformational dynamics and torsion of the
aortic root as compared with rigid structure of mechanical
valve.Study Limitations
The number of patients in the study groups was small.
Thus, the power to comment might be somewhat limited.
However, the main strength of the study relies on the num-
ber of variables analyzed that validate the model for addi-
tional series of patients.CONCLUSIONS
Our study supports the evidence of a significant linkage
among reduced coronary flow, impaired hemodynamic pro-
files, and higher mean prosthetic gradient values in patients
who underwent AVR with persistently high indexed left
ventricular mass. The evaluated valve substitutes provided
both satisfactory hemodynamic results at rest. However,
MMU bioprostheses showed a better behavior with lower
gradients during exercise as compared with SJR valves of
the same ‘‘actual size.’’ The intrinsic characteristics of the
mechanical valve deeply interfered with flow dynamics dur-
ing exercise. Our results and others from similar studies
could support a reassessment of actual guidelines on the
valve choice for AVR regardless of patient age.gery c May 2012
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